| Kelli Brannon Strange, RPH | |
|
1909 Honeysuckle Rd, Dothan, AL 36305-4289 | |
| (334) 836-0890 | |
| (334) 836-0894 |
| Full Name | Kelli Brannon Strange |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1909 Honeysuckle Rd, Dothan, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902121031 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 12640 (Alabama) | Primary |
| 183500000X | Pharmacist | PS0028447 (Florida) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelli Brannon Strange, RPH 1909 Honeysuckle Rd, Dothan, AL 36305-4289 Ph: (334) 836-0890 | Kelli Brannon Strange, RPH 1909 Honeysuckle Rd, Dothan, AL 36305-4289 Ph: (334) 836-0890 |
News Archive
BIOTRONIK SE Co. & KG, a leading manufacturer of cardiac devices, has announced that its innovative new ablation catheter, AlCath Flux eXtra Gold, is now available throughout Europe after receiving CE mark and successfully completing the premarket evaluation in Germany, Italy, Switzerland and several other European countries.
Johns Hopkins researchers say they have discovered a cause-and-effect relationship between two well-established biological risk factors for schizophrenia previously believed to be independent of one another.
Cook Medical has completed patient enrollment in a study evaluating a technique for achieving vascular access via below-the-knee arteries. The new access technique could be used in treating peripheral arterial disease, including patients with critical limb ischemia.
Many health care systems across the US have declined to participate in the Centers for Medicare and Medicaid Services' (CMMS) Accountable Care Organization (ACO) program, developed under the Patient Protection and Affordable Care Act (PPACA), to improve efficiency and quality of health care delivery.
The United States Food and Drugs Administration (FDA), in a statement this week, approved a new drug Lucemyra (lofexidine hydrochloride) for the treatment and alleviation of opioid symptom withdrawal symptoms in adults in whom the drugs have been withdrawn abruptly.
› Verified 4 days ago
Burton L Hill, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4601 Montgomery Hwy, Dothan, AL 36303 Phone: 334-340-1113 | |
Ms. Frances Juanita Krumnow, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2140 E Main St, Dothan, AL 36301 Phone: 334-712-6638 | |
Lindsey Michele Wheeless, LINDSEY WHEELESS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4030 W Main St, Dothan, AL 36305 Phone: 334-792-2261 Fax: 334-673-0492 | |
Wendy Herring, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3574 Montgomery Hwy, Dothan, AL 36303 Phone: 334-671-3701 | |
Jacey Leigh Calhoun, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1909 Honeysuckle Rd, Dothan, AL 36305 Phone: 334-836-0890 | |
Dr. Joseph Shane Bell, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1620 Ross Clark Cir, Dothan, AL 36301 Phone: 334-673-1208 Fax: 334-673-1215 | |
Sheena Renae Hinton, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1955 E Main St, Dothan, AL 36301 Phone: 334-794-7798 Fax: 334-678-8158 |